Retrospective review evaluates clinical outcomes of patients with neuroendocrine carcinoma of the cervix, suggesting surgery may improve survival rates.
Key Points
Median overall survival was significantly longer for patients undergoing primary surgery compared to those receiving chemoradiation.
This analysis included a total of 32 patients diagnosed between 2007 and 2023, with a median follow-up of 14.5 months.
The study found that 31.3% of patients were diagnosed at stage IVB, indicating advanced disease at the time of diagnosis.
Most treatment failures resulted from distant metastatic relapse, with 75% of patients experiencing this outcome.